Pivoting Towards Precision: Cancer Genomic Profiling via Next-Generation Sequencing (NGS)
At the turning point of cancer treatment, personalized medicine has become the core of enhancing therapeutic efficacy and survival rates. Since every tumor possesses a unique mutational profile, Weshin Inspection Tech offers Next-Generation Sequencing (NGS) services that scan hundreds of cancer-related genes simultaneously, providing the deepest molecular insights for clinical decision-making and drug development.
Why Choose Next-Generation Sequencing (NGS)?
Traditional methods, such as single-locus PCR, are limited to detecting one mutation at a time. In contrast, NGS technology acts as a massive scanner for "biological barcodes," offering several key advantages:
-
High-Throughput Analysis: Concurrent detection of Single Nucleotide Variants (SNVs), Insertions/Deletions (Indels), Copy Number Variations (CNVs), and Gene Fusions.
-
Superior Sensitivity: Accurately captures genetic signals even in samples with low tumor content or trace DNA from Liquid Biopsies.
-
Guided Targeted Therapy: Identifies actionable mutations for targeted drugs, evaluates immunotherapy biomarkers (e.g., TMB, MSI), and monitors the emergence of drug resistance.
Technical Excellence of Weshin Inspection Tech
The success of cancer genomic profiling hinges on the precision of library preparation and data interpretation.
-
Expert Primer Design & Probe Technology: To address the high complexity of cancer genomes, Weshin leverages professional primer design expertise to customize experimental protocols, ensuring high coverage of target regions tailored to client needs.
-
Comprehensive Specimen Processing: We maintain validated purification and amplification workflows for various sample types, including Formalin-Fixed Paraffin-Embedded (FFPE) tissues, fresh tissues, and blood (Liquid Biopsy).
-
Advanced Bioinformatic Interpretation: Utilizing robust analytical pipelines, we transform complex sequencing data into clinically relevant reports, helping to identify critical driver mutations.
Click to Pay
